USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Ansata Therapeutics, Inc.
Address:
505 COAST BLVD S
505 COAST BLVD S
La Jolla, CA 92037
Phone:
(858) 754-3000
URL:
N/A
EIN:
43648629
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $240,894.00 1

Award List:

Peptide Transduction-based Therapies for CF

Award Year / Program / Phase:
2003 / STTR / Phase I
Award Amount:
$240,894.00
Agency:
HHS
Principal Investigator:
Brian A. Pollok
Research Institution:
UNIVERSITY OF PITTSBURGH
RI Contact:
N/A
Abstract:
DESCRIPTION: (provided by applicant): Cystic fibrosis (CF) is a genetic disease caused by mutations in the gene encoding CFTR that results in a significantly shorter lifespan as well as associated pathologies. Unfortunately, none of the currently available treatments are able to halt the progression… More